Diagnos Laboratorium Utama Tbk. vs Erajaya Swasembada Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Erajaya Swasembada Tbk. trades at Rp456 (market cap 7.27T, 91.25M 24h volume). The key difference: Erajaya Swasembada Tbk. is far larger — about 23× Diagnos Laboratorium Utama Tbk.'s market cap, and Erajaya Swasembada Tbk. is more actively traded (91.25M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | ERAA | |
|---|---|---|
Market Cap | 316.25B | 7.27T |
Volume | 41.7K | 91.25M |
Lot | 417 | 912.49K |
Turnover | 9.66M | 42.38B |
Average Price | 231.65 | 464.46 |
Value | 9.66M | 42.38B |
Indicative Equilibrium Price | 230 | 456 |
Indicative Equilibrium Volume | 2.4K | 26K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Erajaya Swasembada Tbk (the Company) was established in Jakarta based on Notarial Deed No.7 of Myra Yuwono, S.H., dated October 8, 1996. Erajaya Group is the official distributor for 10 international mobile communication brands and an authorised partner for major mobile operators. Recently, the Group has launched its own mobile handset under the name of Venera. In 1996, PT Erajaya Swasembada, or Erajaya, the establishment of what we know today as the Erajaya Group, was incorporated.
Read more on ERAA →